Back to search
Systemic Lupus Erthematosus (SLE)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Systemic Lupus Erthematosus (SLE) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Systemic Lupus Erthematosus (SLE) trials you may qualify forThe goal of this prospective observational quality improvement study is to determine if a physician tool, MedSafer, combined with educational brochures for pati…
This is an exploratory, open-label, single-arm Phase 1 clinical study designed to evaluate the safety, tolerability, and preliminary efficacy of QT-219C. QT-219…
This Phase 1, open label, dose escalation study evaluates the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of HB2…
to evaluate the safety and efficacy of GR1803 in the treatment of patients with systemic lupus erythematosus
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated autoimmune disease.
The goal of this clinical trial is to evaluate the safety and effectiveness of UC-MSCs in adults with systemic lupus erythematosus (SLE). The main questions th…
Budoprutug is a humanized, immunoglobulin (Ig) G1 monoclonal antibody that selectively binds to CD19 and is projected to deplete targeted cells through antibody…
The goal of this clinical trial is to learn about the safety, pharmacokinetics and pharmacodynamics profile of KN5501 cell injection in adults with systemic lup…
Systemic lupus erythematosus (SLE) is a life-long systemic autoimmune disease with a large variability in its clinical course. The onset of SLE during childhood…